Publications by authors named "O Van Delden"
Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review.
Eur Urol Oncol
December 2024
Background And Objective: Current guidelines on radiological follow-up (FU) for patients after treatment for nonmetastatic renal cell carcinoma (RCC) are not based on robust evidence. This review aims to evaluate whether the 2022 European Association of Urology (EAU) guidelines are noninferior, in terms of recurrence and (overall) survival, to a higher imaging frequency of computed tomography (CT) of the chest and abdomen.
Methods: A literature search of relevant search machines (PubMed/Medline and EMBASE) was performed up to May 29, 2024.
Objective: The impact of the coronavirus disease 2019 (COVID-19) on hepatocellular carcinoma (HCC) care is unclear. This study reports on HCC patterns during the COVID-19 pandemic in the Netherlands.
Methods: Patients diagnosed with HCC between 2017 and 2020 were identified from the Netherlands Cancer Registration.
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial.
United European Gastroenterol J
October 2024
Background And Aims: Our purpose was to assess the impact of muscle quality on overall survival (OS) in patients with advanced HCC.
Methods: This is a subanalysis of the SORAMIC trial. Overall, 363 patients were included.
Article Synopsis
- The study investigates the imaging characteristics in gadoxetic acid-enhanced MRI that differentiate focal nodular hyperplasia (FNH) from hepatocellular adenoma and carcinoma (HCA/HCC), particularly focusing on hyper- or isointensity observed in the hepatobiliary phase.
- Researchers analyzed data from 124 patients with pathology-proven FNH or HCA/HCC, finding unique imaging traits such as specific patterns and fat content that help distinguish between these liver conditions.
- The results suggest that if certain imaging characteristics indicative of HCA/HCC are present, further evaluation should be conducted to rule out B-catenin-activated HCA, especially when lesions show high levels of hyper- or isointensity.
Introduction: This study investigates the incidence of extrahepatic perfusion and incomplete hepatic perfusion at intraoperative methylene blue testing and on postoperative nuclear imaging in patients undergoing hepatic arterial infusion pump (HAIP) chemotherapy.
Methods: The first 150 consecutive patients who underwent pump implantation in the Netherlands were included. All patients underwent surgical pump implantation with the catheter in the gastroduodenal artery.